Trial Profile
Efficacy and tolerability of sumatriptan (10 and 20mg) in patients with moderate or severe migraine
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2016
Price :
$35
*
At a glance
- Drugs Sumatriptan (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 02 Nov 2010 New trial record
- 29 Oct 2010 Results will be presented at the 2nd European Headache and Migraine Trust International, according to a OptiNose media release.